|
|
|
|
|
| |
|
|
International Clinical Trials
|
|
|
ICT is a specialist journal designed to provide global coverage of key topics pertinent
to the clinical trials sector.
|
|
| |
|
|
| |
|
|
European Biopharmaceutical Review
|
|
|
|
EBR is well-recognised for providing beneficial information to players in the bio-industry including entrepreneurial biopharmaceutical and life science companies
|
|
|
|
|
Website design and development by Rubler Studio
|
|
|
.
 |
News and Press Releases |
 |
Merck Announces Collaboration with Agilent Technologies to Fill Industry Gap in Process Analytical Technologies for Downstream Processing
Darmstadt, Germany, June 14, 2022: Merck, a leading science and
technology company, today announced that it has entered a collaboration
with Agilent Technologies to advance Process Analytical Technologies
(PAT). PAT, which is strongly encouraged by global regulatory
authorities, is a key enabler for real-time release and Bioprocessing
4.0.
More info >> |
|
.
 |
White Papers |
 |
|
Driving ROI: The Case for Investing in Contract & Site Regulatory Document Management Services
DrugDev
With tight timelines and complicated regulatory documentation requirements, getting a clinical trial up and running quickly is easier said than done. Key milestones can be achieved only after the successful negotiation of clinical trial agreements and completion of essential regulatory documents. Many clinical trials are hindered by inefficient, labor-intensive processes. Prolonged, inefficient activation can hamper investigator satisfaction and, ultimately, have a negative bottom-line impact for sponsors and CROs. In addition, the Sunshine Act is heightening the importance of financial disclosure in clinical trials. Without a robust financial disclosure strategy, sponsors cannot ensure that physician self-reported financial disclosure data are aligned with the payment data being reported through the Sunshine Act, increasing financial and regulatory risk.
More info >> |
|
|
|
